Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient‐derived, advanced prostate cancer tissue xenograft model

The current first‐line treatment for advanced metastatic prostate cancer, i.e. docetaxel‐based therapy, is only marginally effective. The aim of the present study was to determine whether such therapy can be improved by combining docetaxel with Aneustat (OMN54), a multivalent botanical drug candidat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Oncol
Hlavní autoři: Qu, Sifeng, Wang, Kendric, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Liu, Chengfei, Gao, Allen C., Gout, Peter W., Collins, Colin C., Wang, Yuzhuo
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2013
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528545/
https://ncbi.nlm.nih.gov/pubmed/24388358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2013.12.004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky